• FirefoxInstall the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    Lexicon Pharmaceuticals, Inc. (LXRX)

    -NasdaqGS
    0.94 0.01(0.60%) Feb 26, 4:00PM EST
    Add to Portfolio
    Prev Close:0.94
    Open:0.95
    Bid:0.90 x 3000
    Ask:0.97 x 1000
    1y Target Est:2.75
    Beta:1.36
    Earnings Date:Feb 27 - Mar 2 (Est.)
    Day's Range:0.93 - 0.95
    52wk Range:0.80 - 2.00
    Volume:6,132,845
    Avg Vol (3m):1,829,240
    Market Cap:485.54M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LXRX

    Comparison

    Symbol% ChgMkt Cap
    LXRXUp 0.60%485.54M
    DGENN/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):173.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.20
    Quarterly EPS Est (Dec-14) :-0.03
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for human disease. Its drug development programs include LX4211, an orally-delivered small molecule compound that has completed two Phase II clini... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback